ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -20.0% | 3 | 0.0% | 0.00% | – |
| Q2 2023 | $5 | -68.8% | 3 | -86.4% | 0.00% | – |
| Q1 2023 | $16 | -98.6% | 22 | -98.9% | 0.00% | – |
| Q4 2022 | $1,123 | -99.9% | 1,938 | +56.7% | 0.00% | – |
| Q3 2022 | $1,175,000 | -97.6% | 1,237 | -97.0% | 0.00% | – |
| Q2 2022 | $49,160,000 | +382.5% | 40,967 | +426.8% | 0.00% | – |
| Q1 2022 | $10,188,000 | -96.7% | 7,777 | -95.6% | 0.00% | – |
| Q4 2021 | $308,192,000 | +688.3% | 175,109 | +872.0% | 0.00% | – |
| Q3 2021 | $39,095,000 | -23.0% | 18,016 | +24.1% | 0.00% | – |
| Q2 2021 | $50,799,000 | -66.0% | 14,514 | -4.2% | 0.00% | – |
| Q1 2021 | $149,340,000 | +22.0% | 15,146 | +34.1% | 0.00% | – |
| Q4 2020 | $122,449,000 | -93.6% | 11,296 | -93.9% | 0.00% | -100.0% |
| Q3 2020 | $1,901,081,000 | -10.8% | 184,571 | +80.8% | 0.00% | -25.0% |
| Q2 2020 | $2,131,410,000 | +29.7% | 102,079 | -39.3% | 0.00% | +33.3% |
| Q1 2020 | $1,643,226,000 | -11.0% | 168,191 | +5.0% | 0.00% | 0.0% |
| Q4 2019 | $1,846,103,000 | +3826.9% | 160,252 | +1757.8% | 0.00% | – |
| Q3 2019 | $47,012,000 | -35.6% | 8,626 | +40.5% | 0.00% | – |
| Q2 2019 | $73,005,000 | -15.6% | 6,140 | -62.8% | 0.00% | – |
| Q1 2019 | $86,481,000 | +224.3% | 16,504 | +94.9% | 0.00% | – |
| Q4 2018 | $26,668,000 | -90.9% | 8,466 | -64.6% | 0.00% | – |
| Q3 2018 | $294,484,000 | +14.1% | 23,925 | -0.1% | 0.00% | – |
| Q2 2018 | $258,084,000 | +737282.9% | 23,945 | +398983.3% | 0.00% | – |
| Q1 2018 | $35,000 | +66.7% | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $21,000 | -4.5% | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $22,000 | +46.7% | 6 | 0.0% | 0.00% | – |
| Q2 2017 | $15,000 | -89.1% | 6 | -88.2% | 0.00% | – |
| Q1 2017 | $138,000 | -87.0% | 51 | -86.1% | 0.00% | – |
| Q4 2016 | $1,064,000 | -83.3% | 367 | -76.3% | 0.00% | – |
| Q3 2016 | $6,375,000 | +124.6% | 1,551 | +72.7% | 0.00% | – |
| Q2 2016 | $2,838,000 | – | 898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |